SCHEMBL21276751

SCHEMBL21276751

CNc1ccc(C#Cc2ccc(OCCCN3CCOCC3)cc2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 3/20 0.54
▸ MAPK1 P28482 2/20 0.54
▸ CHRM1 P11229 2/20 0.54
▸ HTR2A P28223 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CHRM2 P08172 1/20 0.54
▸ SCN1A P35498 1/20 0.54
▸ HTR2B P41595 1/20 0.54
▸ KCNH2 Q12809 1/20 0.54
▸ SCN2A Q99250 1/20 0.54
▸ SIGMAR1 Q99720 1/20 0.54
▸ SCN3A Q9NY46 1/20 0.54
▸ USP2 O75604 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ HRH2 P25021 1/20 0.51
▸ HRH1 P35367 1/20 0.51
▸ EPHX2 P34913 5/20 0.49
▸ MCHR1 Q99705 4/20 0.49
▸ CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21276824 0.87 HRH3 (0.51) HRH3MAPK1CHRM1HTR2AALDH1A1
SCHEMBL21276670 0.81 MCHR1 (0.50) HRH3CHRM1HTR2ACYP1A2HRH2
SCHEMBL21276770 0.79 MCHR1 (0.50) HRH3CHRM1HTR2ACYP1A2HRH2
SCHEMBL17447607 0.78 RET (0.65) —
SCHEMBL21276813 0.77 MAPK1 (0.44) HRH3MAPK1CHRM1HTR2AALDH1A1
SCHEMBL21276708 0.77 HRH3 (0.59) HRH3MAPK1CHRM1HTR2AALDH1A1
SCHEMBL113405 0.76 LTA4H (0.63) HRH3MAPK1CHRM1HTR2AALDH1A1
SCHEMBL17447654 0.76 RET (0.67) —
SCHEMBL21276704 0.76 ACACB (0.53) HRH3MAPK1CHRM1HTR2AALDH1A1
SCHEMBL18763519 0.75 HRH3 (0.65) HRH3MAPK1CHRM1HTR2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169671-B1 1-(5-(TERT.-BUTYL)ISOXAZOL-3-YL)-3-(4-((PHENYL)ETHYNYL)PHENYL)UREA DERIVATIVES AND RELATED COMPOUNDS AS FLT3 INHIBITORS FOR TREATING CANCER SUNSHINE LAKE PHARMA CO LTD (CN) 2019-08-21 — — EP disclosed
Send feedback